Heska Corporation (HSKA) Social Stream



Heska Corporation (HSKA): $95.04

-0.13 (-0.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Heska Corp (HSKA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Heska Corp.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 3 $300 $280 $290 $138.45 109.46%
2021-11-18 4 $300 $190 $256.666 $138.45 85.39%
2022-01-24 5 $300 $190 $245 $138.45 76.96%
2022-02-23 5 $280 $190 $232.5 $138.45 67.93%
2022-02-28 5 $280 $161 $225.25 $138.45 62.69%
2022-03-17 5 $280 $161 $220.25 $138.45 59.08%

The Trend in the Analyst Price Target


HSKA's average price target has moved down $66.75 over the prior 31 weeks.

HSKA reports an average of 19.51% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 6 240 182 221.75 196.55 12.82%
2021-06-13 6 240 182 221.75 206.22 7.53%
2021-08-28 6 310 225 287.00 264.16 8.65%
2021-09-18 6 310 225 282.50 260.86 8.3%
2022-03-17 5 280 161 220.25 138.69 58.81%

HSKA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 3 0 2 0 0 5

The Trend in the Broker Recommendations


Over the past 26 weeks, HSKA's average broker recommendation rating improved by 0.37.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Heska Corp's average analyst price target is higher than 640.67% of them.
  • In terms of how Heska Corp fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 142.27% of that group.
  • Heska Corp's upside potential (average analyst target price relative to current price) is greater than 524.51% of stocks in the mid market cap category.
  • HSKA has a lower variance in analysts' estimates than -276.41% of stocks in the mid market cap category.

Stocks similar to Heska Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CLDX, ZYME, and ZNTL.

Is HSKA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6515 seconds.